Phospho-CREB (Ser133) (87G3) Rabbit Mono…

The University of Nebraska Medical Center (UNMC), a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order to Cell Signaling Technology Inc., headquartered in Boston, Massachusetts, on June 11, 2026. The contract, valued at $979, covers the procurement of one unit of Phospho-CREB (Ser133) (87G3) Rabbit Monoclonal antibody (material number 9198L). Delivery is scheduled for June 17, 2026, to UNMC General Supply in Omaha, Nebraska, with freight prepaid and delivery terms established as Free on Board (F.O.B.) Destination. Payment terms are Net 30, with billing directed to the UNMC Accounts Payable department.

This purchase order, governed by the Standard Terms of Purchase established by the University of Nebraska, represents a procurement of research-grade biological reagents for use at the UNMC facility. The vendor is required to acknowledge the purchase order within ten days and ensure that the purchase order number appears on all packages, invoices, and related documentation. The contract period spans six calendar days, from award through the scheduled delivery date of June 17, 2026.